pharmaceutical industry

Stefan Oelrich, Member of Bayer's Board of Management and Head of the Pharmaceuticals Division, is confident about the development pipeline. As one important patent expires, he points to a range of new products that will generate big sales.

Big Pharma is gradually pulling away from the consumer health sector. Stepping in to take its place are the consumer goods conglomerates.